• Hypertrophic Cardiomyopathy (HCM)
  • Vaccines: 2023 Year in Review
  • Eyecare
  • Urothelial Carcinoma
  • Women's Health
  • Hemophilia
  • Heart Failure
  • Vaccines
  • Neonatal Care
  • NSCLC
  • Type II Inflammation
  • Substance Use Disorder
  • Gene Therapy
  • Lung Cancer
  • Spinal Muscular Atrophy
  • HIV
  • Post-Acute Care
  • Liver Disease
  • Pulmonary Arterial Hypertension
  • Biologics
  • Asthma
  • Atrial Fibrillation
  • Type I Diabetes
  • RSV
  • COVID-19
  • Cardiovascular Diseases
  • Breast Cancer
  • Prescription Digital Therapeutics
  • Reproductive Health
  • The Improving Patient Access Podcast
  • Blood Cancer
  • Ulcerative Colitis
  • Respiratory Conditions
  • Multiple Sclerosis
  • Digital Health
  • Population Health
  • Sleep Disorders
  • Biosimilars
  • Plaque Psoriasis
  • Leukemia and Lymphoma
  • Oncology
  • Pediatrics
  • Urology
  • Obstetrics-Gynecology & Women's Health
  • Opioids
  • Solid Tumors
  • Autoimmune Diseases
  • Dermatology
  • Diabetes
  • Mental Health

Prioritize data in the context of overall objectives

Article

With existing data and the tidal wave of data to come, care management can achieve significant improvements

If you consider data as the root of the process-improvement tree, then clinical data may well be considered the root of a care-management tree.

This care-management tree has many branches: medication adherence, hospital readmission prevention, better coordination of care, closing gaps in care, etc. All of them depend on broad, healthy roots to grow.

IMPROVE CARE MANAGEMENT

Examples include: identify and intervene with members at risk for emergency department visits due to medication non-adherence; identify and intervene with members at risk for adverse drug events; and narrow the time between hospital discharge and active care management.

For example, while lab values are essential to identifying gaps in care and whether outcomes are improving, they can be difficult to integrate into a patient-centric database because the data capture is discrete and remote.

While the need for more robust and sophisticated use of clinical data is likely to grow within your enterprise, supporting a discrete service is a more manageable and realistic first step for deploying clinical data analytics than looking at a broader shift in your enterprise technology.

Ahmed Ghouri, MD, is chief medical officer and co-founder of Anvita Health.

Related Videos
Video 4 - "Assessing the Cost-Effectiveness of Prescription Digital Therapeutics "
Video 3 - "Harnessing Prescription Drug Therapeutics as Monotherapy and Adjunct Therapy"
Video 8 - "Demographic Differences That Impact Care"
Video 7 - "Gaps in Diabetes Education and Self Efficacy"
Video 6 - "Developing Reimbursement Models for Digital Therapeutics"
Video 5 - "Cost-Effectiveness Metrics Payers Seek for Digital Therapeutics"
Video 2 - "Bridging Care Gaps with Prescription Digital Therapeutics"
Related Content
© 2024 MJH Life Sciences

All rights reserved.